The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

OMNISEC is a top of the range multi-detector gel-permeation/size-exclusion chromatography (GPC/SEC) system from Malvern ...

Steqeyma is now supplied as a 45mg/0.5mL solution in a single-dose vial for subcutaneous injection, allowing for weight-based dosing for pediatric patients under 60kg.

A recent webinar from BD shared important insights into patient fear and anxiety over self-injection and how the right device ...

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

One that could expose your most sensitive information to attackers. Software developer and AI researcher Simon Willison calls this the “lethal trifecta” of AI agent design.